Dr. Humaira Rizvi, MD

Dr. Rizvi practices at Henry Ford St. John Hospital in Detroit, Michigan, part of Henry Ford Health.

Dr. Rizvi's NPI, 1225447766, was assigned on August 8, 2014. Dr. Rizvi holds Michigan license 3618847.

Dr. Rizvi's primary practice is Henry Ford St. John Hospital, at 22101 Moross Rd, Detroit, MI 48236 in Wayne County. The practice phone is (313) 343-4000.

Dr. Rizvi's primary practice is Henry Ford St. John Hospital in Detroit, Michigan, part of Henry Ford Health. Dr. Rizvi is also affiliated with Henry Ford Hospital. The medical group on file is Great Lakes Medical Group. Dmand AI also links Dr. Rizvi to 1 more hospital, 2 medical groups, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rizvi practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Rizvi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Rizvi is licensed in Michigan.

CMS data shows 164 Medicare services from Dr. Rizvi across 5 procedure codes in 2024, for 89 Medicare patients. Medicare paid $11,160 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 89 Medicare patients who saw Dr. Rizvi in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.83, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rizvi's median patient age at 67, with 54% women.

In 2019, Dr. Rizvi wrote 13 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $136 in total drug cost. In 2018, CMS named 15 claims across 1 drug.

Dr. Rizvi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Rizvi, published from 2016 to 2017. Dr. Rizvi's most frequent co-authors are Uqba Khan, MD, Jane Chiu, MD and Tarik Hikmat Hadid, MD.

CMS Open Payments shows 2 general payments to Dr. Rizvi from 2 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. ViiV Healthcare Company paid the most, $26.